|
Çѱ¹¾ËÄÜ |
[ALCON] Regulatory Affairs (RA) Specialist – °æ·Â
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
09.27 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Regulatory Affairs Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
06.19 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] RA Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
01.13 |
|
|
(ÁÖ)Äɾî»çÀ̵å |
[Á¦¾à/¹ÙÀÌ¿À] RAÆÀ ÀÎÇã°¡°ü¸® °æ·ÂÁ÷ ¿¬±¸¿ø
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
04.26 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Regulatory Affairs Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
06.09 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Regulatory Affairs Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
06.12 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Regulatory Affairs Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
08.04 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
ÀÎÇã°¡»ç¾÷ºÎ Drug Team °æ·ÂÁ÷ ä¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
12.12 |
|
|
(ÁÖ)Æĸ¶ÄÚ½ºÅØ |
½Å¾à°³¹ß RA °æ·ÂÁ÷ ¸ðÁý
´ëÀü À¯¼º±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
06.30 |
|
|
¾ÆÀÌÅ¥¾î(ÁÖ) |
ÇØ¿ÜRA °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
04.16 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] RA Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
01.10 |
|
|
(ÁÖ)¿¤¾ØÄÉÀ̹ÙÀÌ¿À¸Þµå |
(ÄÚ½º´Ú)Spine ÀÇ·á±â±â R&D ¿¬±¸¼Ò ä¿ë(¿¬±¸°³¹ß/RA)
¼¿ï ¾çõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
08.18 |
|
|
µ¿ÁøÆĸ¶ÁÖ½Äȸ»ç |
µ¿ÁøÆĸ¶ RAÆÀ °æ·ÂÁ÷ ¸ðÁý(Á¤±ÔÁ÷)
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
12.24 |
|
|
ÁÖ½Äȸ»ç Å¥¶óƼ½º |
¿À¼Û ¹ÙÀÌ¿ÀÇ÷£Æ® MSAT ºÎ¹® Á¤±ÔÁ÷ ¸ðÁý (ÀÎÇã°¡ÆÄÆ®, MS
ÃæºÏ ûÁֽà Èï´ö±¸ | °íµîÇб³ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
09.13 |
|
|
¿¡À̵ð¿¥ÄÚ¸®¾Æ(ÁÖ) |
RA Á÷¿ø ä¿ë
¼¿ï Á¾·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
10.20 |
|